March 11, 2024
Opioid/Substance Use Disorders | Tea Leaves
  • Consulting giant McKinsey & Company agreed to a $78 million settlement in a case over its role in advising opioid manufacturers to design misleading marketing campaigns. A group of U.S. health insurers and company benefit plans, referred to in court documents as third-party payers, alleged in the suit that the firm helped add fuel to the fire in the opioid abuse epidemic by advising drug manufacturers such as Purdue Pharma in crafting deceptive marketing campaigns for opioids. If the settlement is approved, McKinsey would have two weeks from the approval date to pay $78 million to the plaintiffs by wire. The payment would establish a fund to reimburse third-party payers for some or all of their prescription opioid costs. (Article here)